🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
299,00 USD
Máx. histórico
322,75
6 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-7,36%
Rango 52 semanas
175,89 – 326,63
Variación hoy
-5,42%
Cierre anterior
316,13
Rango de hoy
297,63 – 318,98
Volumen hoy
247.610
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 120,08 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 7 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 14/04/2020 | 57,39 | 59,18 | 56,19 | 56,84 | +1,23% | 5,20% | 834.842 |
| 13/04/2020 | 54,58 | 56,58 | 53,03 | 56,15 | +4,15% | 6,50% | 554.157 |
| 09/04/2020 | 52,60 | 54,83 | 51,49 | 53,91 | +4,11% | 6,36% | 669.894 |
| 08/04/2020 | 49,00 | 53,03 | 48,66 | 51,78 | +6,11% | 8,91% | 685.122 |
| 07/04/2020 | 49,91 | 51,41 | 48,35 | 48,80 | +1,02% | 6,13% | 972.380 |
| 06/04/2020 | 48,07 | 50,19 | 46,21 | 48,31 | +5,75% | 8,28% | 1.200.487 |
| 03/04/2020 | 44,82 | 46,53 | 44,27 | 45,68 | +1,78% | 5,04% | 906.176 |
| 02/04/2020 | 42,41 | 47,53 | 41,95 | 44,88 | +5,38% | 13,15% | 1.299.552 |
| 01/04/2020 | 43,94 | 45,18 | 41,97 | 42,60 | -6,11% | 7,33% | 1.035.217 |
| 31/03/2020 | 44,52 | 47,07 | 43,37 | 45,36 | +2,12% | 8,31% | 1.289.774 |
| 30/03/2020 | 42,14 | 44,50 | 41,21 | 44,42 | +6,62% | 7,82% | 863.536 |
| 27/03/2020 | 44,10 | 44,82 | 41,60 | 41,67 | -8,41% | 7,30% | 1.195.517 |
| 26/03/2020 | 43,80 | 46,30 | 42,69 | 45,49 | +4,31% | 8,23% | 1.149.511 |
| 25/03/2020 | 46,31 | 48,07 | 42,84 | 43,61 | -5,76% | 11,29% | 939.198 |
| 24/03/2020 | 44,60 | 47,54 | 43,54 | 46,28 | +5,16% | 8,97% | 1.109.757 |
| 23/03/2020 | 47,67 | 47,67 | 43,26 | 44,01 | -3,20% | 9,24% | 769.600 |
| 20/03/2020 | 51,25 | 51,66 | 42,69 | 45,46 | -10,05% | 17,49% | 1.293.942 |
| 19/03/2020 | 45,81 | 56,77 | 45,41 | 50,54 | +7,45% | 24,80% | 1.308.048 |
| 18/03/2020 | 45,30 | 51,69 | 44,04 | 47,03 | -4,67% | 16,88% | 1.598.351 |
| 17/03/2020 | 40,18 | 52,51 | 35,71 | 49,33 | +24,79% | 41,83% | 1.730.439 |
| 16/03/2020 | 44,34 | 47,59 | 39,51 | 39,53 | -22,18% | 18,22% | 1.832.229 |
| 13/03/2020 | 53,64 | 53,77 | 43,67 | 50,80 | -0,89% | 18,83% | 1.434.685 |
| 12/03/2020 | 53,80 | 56,13 | 50,92 | 51,25 | -10,53% | 9,67% | 1.345.558 |
| 11/03/2020 | 59,77 | 64,88 | 56,46 | 57,29 | -6,41% | 14,08% | 1.600.596 |
| 10/03/2020 | 61,08 | 61,32 | 55,05 | 61,21 | +3,71% | 10,27% | 1.109.276 |
| 09/03/2020 | 63,53 | 66,93 | 58,98 | 59,02 | -12,03% | 12,52% | 1.603.000 |
| 06/03/2020 | 64,96 | 67,89 | 63,29 | 67,09 | +0,86% | 7,07% | 1.099.498 |
| 05/03/2020 | 65,89 | 67,20 | 64,82 | 66,52 | -1,16% | 3,61% | 574.355 |
| 04/03/2020 | 64,68 | 67,40 | 64,47 | 67,30 | +5,37% | 4,53% | 554.959 |
| 03/03/2020 | 63,87 | 66,70 | 63,39 | 63,87 | -0,40% | 5,18% | 1.020.470 |